Introduction
Platinum-based anticancer drugs are among the most widely used chemotherapeutics and applied in the treatment of a wide range of malignant tumors.
1 Specifically in the treatment of testicular cancer, the introduction of cisplatin increased the survival rate to more than 90% of the diagnosed cases. The platinum chemotherapeutics cisplatin and the second and third generation compounds carboplatin and oxaliplatin, respectively, are now the first line of treatment for bladder, testicular, ovarian, head/neck and colorectal cancers. 2 However, severe toxic effects such as nausea, nephro-and neurotoxicity, and resistance of common cancer types to Pt compounds as well as resistance acquired during treatment limit their application to a great extent.
3
The classic structure-activity relationships for platinum compounds are based on platinum being present as Pt II or Pt IV centers with two cis-configured leaving groups and two stable am(m)ine ligands coordinated to the metal. 4 While the complexes are supposed to remain in their original composition during administration and circulation in the bloodstream, the low chloride concentration in the cell allows a chlorido/aqua exchange to occur. Sequential replacement of the leaving ligands leads to positively charged complexes that interact initially electrostatically with the negatively charged phosphate backbone of DNA before a second step of ligand exchange reactions leading to the platination of DNA. Platinum is found most commonly attached to guanine residues in the major groove and to a lesser extent to adenine moieties. In particular, the presence of adjacent guanines residues has been found to be advantageous to support the binding event between the platinum center and DNA, leading to DNA lesions that cannot be repaired easily and trigger apoptosis.
5
The nature of the leaving ligand(s) has been shown to be crucial for reducing the side effects, and this has especially been demonstrated for the second and third generation compounds, carboplatin and oxaliplatin, which feature the negatively charged cyclobutanedicarboxylato and oxalato ligands, respectively. 5c,6 However, there are also neutral ligands that can easily be substituted under physiological conditions. Ligands such as DMF and (CH 3 ) 2 SO have been widely used in the preparation of complexes and their metal species are often identified as intermediates. 6c,7 Furthermore, (CH 3 ) 2 SO is found in the rutheniumbased anticancer agent NAMI-A, which was studied for its antimetastatic effects in two clinical trials before being ruled out recently.
8
More recently, interest has grown in the so-called rule-breaker compounds that do not follow the classic structure-activity relationships recognized for the established anticancer agents and their close analogs. Such rule-breakers are for example transconfigured Pt II complexes, but also multinuclear platinum compounds have been investigated and the latter even reached clinical trials due to their potential to overcome cisplatin resistance at least in cell culture. Such non-classic compounds have been suggested to interact with DNA in a different manner from the platinum cis-complexes and thereby would have a different mode of action that may help to overcome the drawbacks of platinum-based chemotherapy. city of three species of each class was screened in the human cancer cell lines CH1/PA-1, A549, SK-BR-3, and SW480, where the MTT assay revealed only marginal activity for the three amidoxime complexes, moderate activity for two of three amidoximato complexes, but a remarkably high cytotoxic potency for the complex bearing a p-trifluoromethylbenzamidoximate ligand, especially in the SW480 cell line. All our studies are consistently disclosed in sections that follow.
Results and discussion
Platinum(II) ketoxime complexes have been extensively studied for the last two decades and data related to these species indicated that ketoximes easily coordinate to the platinum(II) center by the N atom. 10d,12 Such platinum(II) complexes featuring N-bound oximes react with excess platinum(II) to obtain two-or trinuclear species featuring m
In spite of that, amidoxime platinum(II) complexes are still remarkably less explored, whereas amidoxime complexes of other metals are studied as well as conventional oxime complexes. 13 Thus, only four platinum(II) complexes featuring amidoxime ligands are presented in the literature (Fig. 1 The generation of type II complexes proceeds either with oxophilic metal centers or in the presence of a base due to the deprotonation of the O atom resulting in an increase of its nucleophilicity. The coordination of amidoximes by the O atom in basic media commonly is accompanied by the deprotonation of the NH 2 moiety with consequent chelation of the metal center giving type IV complexes. Type III complexes are mostly realized at electron-deficient metal centers, viz., early transition metals or f-elements.
In this work, we decided to comprehensively investigate the preparation of amidoxime platinum(II) complexes with a particular purpose of finding selective routes for the generation of complexes with a well-defined coordination mode of amidoxime ligands. We planned the selective preparation of the complexes of types I, II, and IV by variation of the acidity of the reaction mixtures, whereas complexes of type III are hardly accessible at a rather electron-rich platinum(II) center. Previously, it was reported that the amidoxime OH group can be effectively deprotonated by NaOH in alcohol media 15 and, concurrently, amidoximes can be protonated at the oxime N atom by strong acids. 13 Because of these reasons, we decided to use NaOH and TfOH to vary the acidity of the reaction mixtures and to employ MeOH as a solvent. A characteristic feature of the positive-mode high-resolution ESI mass spectra of 3a-b and 3d-f is the availability of sets of peaks related to fragmentation and quasi-ions corresponding
In the IR spectra of 3a-b and 3d-f, we observed two or three medium-strong to very strong bands in the region of 3480-3215 cm À1 , which can be attributed to the O-H and N-H stretches, and a set of weak to medium bands at 3187-2785 cm À1 assignable to the C-H stretches. 18 All spectra also display one very strong band in the 1663-1655 cm À1 region specific for the n(CQN) of the amidoxime moiety 13 and one medium to very strong band at 1138-1105 cm À1 characteristic of the n(SQO) stretches of sulfur-bound sulfoxides. 19 In addition, the spectrum of 3f displays two very strong bands at 1520 and 1346 cm À1 specific for asymmetric and symmetric n(NQO) bands of the NO 2 moiety.
18
Complexes 3a-b and 3d-f are almost insoluble in the common deuterated organic solvents (CDCl 3 , CD 2 Cl 2 , (CD 3 ) 2 CO, and D 2 O) apart from (CD 3 ) 2 SO and CD 3 OD. In (CD 3 ) 2 SO, the exchange of ligated (CH 3 ) 2 SO with the solvent molecules occurs for 5 min, and therefore the spectra were recorded in CD 3 OD. A characteristic feature of the 1 H NMR spectra is the non-equivalence of the methyl groups of the Me 2 SO ligand. Thus, the spectra of 3a-b exhibit one unresolved broad singlet at 3.45 ppm (3a) or two singlets at 3.46 and 3.44 ppm (3b), whereas the spectra of 3d-f, derived from aromatic amidoximes 2d-f, display two singlets at 3.42-3.37 and 2.83-2.59 ppm. In 3d-f relatively to 3a-b, the highfield shift (0.59-0.78 ppm) of one of the methyl groups of the Me 2 SO ligand should be associated with the shielding effect of the aromatic rings (see X-ray structure determinations). 
Synthesis and characterization of amidoximate complexes 4a-g
The reaction of 1 equiv. of any one of the amidoximes 2a-g with complex 1 in the presence of 2 equiv. of NaOH proceeds in MeOH at 65 1C for 20 min and leads to amidoximate platinum(II) chelated complexes 4a-g (83-98%; Scheme 1b). Compounds 4a-b were not separated from some by-products due to their similar solubilities in organic solvents and in H 2 O and also because of decomposition of the mixture on silica gel. However, the formation of 4a and 4b was confirmed by HRESI , calcd 438.0480). Complexes 4a-g form in a wide range of amidoxime and NaOH ratios. These complexes were isolated (for 4c-g) from the reaction mixtures or detected in the mixtures (for 4a-b see Fig. S26 -S29, ESI †) when 1-10 equiv. of 2a-g and 1-4 equiv. of NaOH were used. It was concluded that, on the one hand, the yields of 4c-g do not significantly depend on the quantity of 2a-g when it was taken in more than 1.1-fold excess. On the other hand, the yields gradually increase with increasing relative quantity of NaOH up to 2.5-fold excess. Upon further addition of the base, the yields decreased for 10-20% in the case to 4-fold excess of NaOH. In these experiments, the formation of the corresponding open-chain species 3 was not detected by HRESI-MS and 1 H NMR. Only when 0.1-2 equiv. of NaOH are , which was not observed for 3a-b and 3d-f, is probably due to protonation of the basic N atom of the oxime group, which is occupied by the platinum center in 3a-b and 3d-f.
In the IR spectra of 3c-g, we observed from one to three weak-medium to medium bands in the region of 3420-3295 cm À1 , which can be attributed to the N-H stretches, and a set of weak to medium bands at 3013-2870 cm À1 assignable to the C-H stretches. 18 All spectra also display one weak to medium band in the 1638-1597 cm À1 region assigned to the n(CQN) of the amidoximate moiety 13 and one strong to very strong band at 1130-1126 cm À1 characteristic of the n(SQO) of sulfur-bound sulfoxides. 19 In addition, the spectrum of 4f displays two strong bands at 1516 and 1341 cm À1 specific for asymmetric and symmetric NQO stretches of the NO 2 moiety.
18
Complexes 3c-g are soluble in the most common deuterated organic solvents, but in (CD 3 ) 2 
X-ray structure determinations
The molecular structures of 3a-b, 3dÁMeOH, 3e-f, 4c, and 4f indicate that all coordination polyhedra exhibit typical squareplanar geometries (Fig. 3) . In the structures of 3a-b, 3dÁMeOH, and 3e-f, all bond angles around the Pt II centers are close to 901, whereas the structure of 4c and 4f display the O(1)-Pt(1)-N (2) 
18
Owing to steric reasons, in 3dÁMeOH and 3e-f, the torsion angles between the aromatic rings and the carbamidoxime moiety are in the range of 49.76-54.921, which indicates partial delocalization between these two groups. In 4f, the torsion angles between the groups in two crystallographically independent types of molecules are 15.60 and 22.041 favoring p-conjugation. In 3dÁMeOH and 3e-f, one of the methyl groups of the ligated Me 2 SO is located above a plane of the aromatic rings with the C 6 Á Á ÁC(4) distances equal 3.642(4)-3.716(5) Å, which lead to a high-field shift of the CH 3 signals in the 1 H NMR spectra. 
Scope and limitations of the reactions
1 H NMR monitoring of the reaction between 2c and 1 in CD 3 OD at RT or 65 1C indicates that the reaction initially (the first 5 min) leads to the formation of at least four unidentified compounds, which, in particular, degrade for 24 h giving a broad mixture of products. Slow evaporation of the reaction mixture gave several crystals of { t BuC(NH 2 )QN(H)OH}[PtCl 3 (Me 2 SO)], whereas the main part is an oily residue. The structure of the mono-sulfoxide complex was verified by single-crystal X-ray diffraction (see Table S2 in the ESI †). A plausible explanation of these observations is steric hindrances provided by the tert-butyl substituent at the oxime N atom preventing the coordination of 2c to the platinum(II) center. 13 Owing to the similar solubilities of the compounds in the mixture and their decomposition on silica gel, no pure components were isolated. We associate the formation of the mixture of products with the availability of an additional nucleophilic center, i.e. the pyridyl N atom, which competes with the amidoxime N atom in coordination to the metal center and provides some side-reactions.
No formation of the bis-amidoxime complexes
Cl was detected even in the presence of 10-fold excess of any one of the amidoximes 2a-g relative to 1 in MeOH at RT or at 65 1C for 10 d. Under these conditions, only the formation of 3a-b and 3d-f was detected and these complexes were isolated in 70-85% yields and no sets of peaks related to the bis-amidoxime complexes were observed in HRESI + -MS spectra. In addition, all attempts of the generation of [PtCl{RC(NH 2 )Q À NOH} 2 (Me 2 SO)](OTf) by treatment of 3a-b or 3d-f with 1 equiv. of AgOTf in MeOH from À20 to 65 1C were unsuccessful due to the formation of broad mixtures of products that we failed to separate.
The amidoximes featuring strong donor substituents R (R = 4-morpholyl, p-Me 2 NC 6 H 4 , and p-MeOC 6 H 4 ) react with 1 at various temperatures in the range from 0 to 65 1C in MeOH, Me 2 CO, and CHCl 3 giving a broad spectrum of unidentified products and they could not be utilized in the reactions described above.
Comparative studies of cytotoxic activity
The antiproliferative activity of six complexes was studied in vitro in four human cancer cell lines by means of the colorimetric MTT assay. Species featuring the chelating amidoximate ligand (4c-e) exhibit higher cytotoxicity in all investigated cell lines compared to their open-chain amidoxime analogues (3b, 3d-e) ( Table 1) .
Complexes 3b and 3d-e display very low activity in these cell lines with IC 50 values consistently exceeding 100 mM and are hence about two orders of magnitude less active than the prototypic oxime complex cis-[PtCl 2 (Me 2 CQ À NOH) 2 ] containing two acetoxime ligands in CH1/PA-1 and SW480 cells. 23 In contrast, most IC 50 values of chelate congeners 4c-e (except for A549 cells) are in the low micromolar to submicromolar range and hence at least one order of magnitude lower than those of the former complexes. In particular, complex 4e bearing a p-trifluoromethylbenzamidoximate ligand shows by far the highest cytotoxic potency and displays a remarkable activity in the inherently cisplatin resistant SW480 cell line (0.51 mM vs. 3.3 mM, Table 1 ). This indicates that the trifluoromethyl substituent in the para position, which differentiates 4e from 4d (bearing an unsubstituted phenyl group), is highly favorable for cytotoxicity, enhancing it by another order of magnitude in CH1/PA-1 and SW480 cells, whereas no such effect could be observed for 3e in comparison to 3d. The results for both classes of complexes are surprising, insofar as the presence of two readily exchangeable chlorido ligands in the cis position is not associated with high cytotoxicity here, whereas the lack of easily exchangeable ligands is. An opposite relationship between the activity of the chelate and open-chain forms was in fact previously shown for the sister class of platinum(II) compounds featuring 1,3-dihydroxyacetone oxime ligands.
10c In contrast, one of the open-chain and not a chelate species had been shown to overcome the resistance of SW480 cells to cisplatin. It has to be borne in mind, however, that the two classes studied here are no such close analogs that can be converted into each other by (de)protonation and chloride subtraction/addition, but additionally differ by the presence of a second dimethyl sulfoxide instead of a chlorido ligand in the amidoximato complexes. In line with current knowledge on platinum drugs, it is reasonable to assume that opening of the chelates is a prerequisite for high biological activity of the amidoximato complexes and that this opening may be favored by trans effects exerted by the sulfur donors destabilizing the opposite bonds. These results are intriguing in the light of the known impact of dimethyl sulfoxide on the biological activity of platinum compounds. When used as a solvent for cisplatin or carboplatin (both having two chlorido ligands), (CH 3 ) 2 SO causes a profound deactivation of the drug due to ligand exchange reactions, whereas the activity of oxaliplatin (having a chelating oxalate as a leaving group) remains virtually unaffected or is slightly enhanced for unknown reasons. 19 A report on the antiproliferative activity of platinum(II) complexes of the type [PtL 2 (Me 2 À SO) 2 ] (where L 2 is a chelating ligand or L is a monodentate ligand) against a set of human cancer cell lines clearly indicates low activity of these complexes relative to non-dimethyl sulfoxide analogs. 24 On the other hand, (CH 3 ) 2 SO ligands are supposed to favor the cellular uptake of metal complexes, and the increase in activity of 4c-e might therefore also arise from the additional (CH 3 ) 2 SO ligand in this group, which may enhance the permeability of the drugs through lipid membranes. 25 
Final remarks
The possibility of pH-dependent highly selective generation of the open-chain amidoxime and chelated amidoximate platinum(II) complexes,
, respectively, has been demonstrated. Although the coordination chemistry of amidoximes has been extensively studied, 13 only one example of coordination isomerism of amidoximes in mononuclear complexes has previously been known, viz. the UO 2 2+ center, amidoximes exhibited k The cytotoxic properties of the novel complexes of both types were examined in four human cancer cell lines (CH1/PA-1, SW480, A549, and SK-BR-3). It was found that chelate amidoximate complexes are significantly more cytotoxic than the open-chain species. Notably, complex 4e displays appreciably enhanced cytotoxicity in the intrinsically cisplatin-resistant SW480 cell line as compared to cisplatin, indicating a promising potential to overcome at least some forms of cisplatin resistance.
Further development of selective preparation of amidoxime complexes of other metals and studies of the cytotoxic activity of complexes featured ligands that structurally similar to amidoximes (amidrazones and hydroxamic acids) are underway in our group.
Experimental section

Materials and instrumentation
Solvents were obtained from commercial sources and used as received. Amidoximes 2a-g were synthesized accordingly to the literature methods.
28 Melting points were measured on a Stuart SMP30 apparatus in capillaries and not corrected. Microanalyses (C, H, N) were carried out on a Euro EA3028-HT instrument. Electrospray ionization mass-spectra were obtained on a Bruker micrOTOF spectrometer equipped with an electrospray ionization (ESI) source. The instrument was operated both in negative and positive ion modes over a m/z range 50-3000. The nebulizer gas flow was 0.4 bar and the drying gas flow was 4.0 L min
À1
. For HRESI, complexes were dissolved in MeOH. In the isotopic pattern, the most intensive peak is reported. Infrared spectra (4000-400 cm H} NMR spectra were measured on Bruker Avance 400 and Bruker Avance III 500 spectrometers at 294-298 K; residual solvent signals were used as the internal standard. The solid-state CP-MAS TOSS 13 C{ 1 H} NMR spectra were measured on a Bruker Avance III WB 400 with magic angle spinning at 6 kHz frequency.
X-Ray structure determinations
XRD experiments were carried out using Agilent Technologies ''Xcalibur'' (for 3a-b, 3dÁMeOH, 3e-f, and 4c) and ''Supernova'' (for 4f) diffractometers with monochromated MoKa or CuKa radiation, respectively. Crystals were fixed on a micro mount, placed on diffractometer and measured at a temperature of 100 K. The unit cell parameters (Tables S1 and S2 , ESI †) were refined by least square techniques in the 2y range of 5.6-55.0 for MoKa and 9.0-150.0 for CuKa. The structures have been solved using the Superflip 29 structure solution program using charge flipping and refined with the ShElXL 30 refinement incorporated in the OLEX2 program package. 31 The carbonbound H atoms were placed in calculated positions and included in the refinement in the 'riding' model approximation, with U iso (H) set to 1.2U eq (C) and C-H 0.97 Å for the CH 2 groups, U iso (H) set to 1.5U eq (C) and C-H 0.96 Å for the CH 3 groups, U iso (H) set to 1.2U eq (C) and C-H 0.93 Å for the CH groups, U iso (H) set to 1.2U eq (N) and N-H 0.88 Å for the NH and NH 2 groups and U iso (H) set to 1.5U eq (O) and O-H 0.82 Å for the OH groups. Empirical absorption correction was applied in the CrysAlisPro 32 program complex using spherical harmonics (for 3a-b, 3dÁMeOH, 3e-f, and 4c), implemented in the SCALE3 ABSPACK scaling algorithm. For 4f, numerical absorption correction based on Gaussian integration over a multifaceted crystal model was applied (Tables S1 and S2 , ESI †). 
Cell lines and culture conditions
Synthetic work
Preparation of amidoxime complexes 3a-b and 3d-f
Powder of cis-[PtCl 2 (Me 2 À SO) 2 ] (1) (84.5 mg; 200 mmol) was added into a stirred solution of any one of the amidoximes 2a-b and 2d-f (200 mmol) in MeOH (3 mL). The suspension was left to stand at 65 1C under stirring for 5 min, whereupon the homogeneous solution formed was cooled to RT and the solvent was evaporated at RT in vacuo. The oily residue was crystallized under CHCl 3 (1 mL) and separated by centrifugation. The precipitate was washed with two 1.5 mL portions of Et 2 O and dried in air at 65 1C. For the characterization of 3a-b and 3d-e, see the ESI. † 3f. Yield: 98% (102.9 mg). Mp: 183 1C (dec). Anal. calcd for C 9 H 13 N 3 Cl 2 O 4 PtS: C, 21.65; H, 3.52; N, 6.39. Found: C, 21.73; H, 3.41; N, 6.48 148.08, 146.40, 138.11, 133.02, 129.73, 123.36, 122.12 (Ar), 46.59, 44.17, 42.66, 40.18 (s, CH 3 O: C, 24.09; H, 3.49; N, 7.66. Found: C, 23.99; H, 3.54; N, 7.65 
